These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


55 related items for PubMed ID: 20154610

  • 1. Genetic determinants of apolipoprotein B-100 kinetics.
    Ng TW, Ooi EM, Watts GF, Chan DC, Barrett PH.
    Curr Opin Lipidol; 2010 Apr; 21(2):141-7. PubMed ID: 20154610
    [Abstract] [Full Text] [Related]

  • 2. Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men.
    Chan DC, Watts GF, Wang J, Hegele RA, van Bockxmeer FM, Barrett PH.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):45-51. PubMed ID: 18031309
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome.
    Watts GF, Ji J, Chan DC, Ooi EM, Johnson AG, Rye KA, Barrett PH.
    Clin Sci (Lond); 2006 Sep; 111(3):193-9. PubMed ID: 16700661
    [Abstract] [Full Text] [Related]

  • 5. Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
    Millar JS, Brousseau ME, Diffenderfer MR, Barrett PH, Welty FK, Faruqi A, Wolfe ML, Nartsupha C, Digenio AG, Mancuso JP, Dolnikowski GG, Schaefer EJ, Rader DJ.
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1350-6. PubMed ID: 16574893
    [Abstract] [Full Text] [Related]

  • 6. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome.
    Chan DC, Watts GF, Barrett PH, O'Neill FH, Thompson GR.
    Obes Res; 2003 Apr; 11(4):591-6. PubMed ID: 12690090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly.
    Rutledge AC, Su Q, Adeli K.
    Biochem Cell Biol; 2010 Apr; 88(2):251-67. PubMed ID: 20453928
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ATP-binding cassette transporter G8 gene as a determinant of apolipoprotein B-100 kinetics in overweight men.
    Chan DC, Watts GF, Barrett PH, Whitfield AJ, van Bockxmeer FM.
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2188-91. PubMed ID: 15331430
    [Abstract] [Full Text] [Related]

  • 12. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells.
    Jin UH, Kang YJ, Chang YC, Kim CH.
    J Cell Biochem; 2008 Feb 15; 103(3):908-19. PubMed ID: 17647275
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
    Ruel IL, Lamarche B, Mauger JF, Badellino KO, Cohn JS, Marcil M, Couture P.
    Arterioscler Thromb Vasc Biol; 2005 Dec 15; 25(12):2600-7. PubMed ID: 16224048
    [Abstract] [Full Text] [Related]

  • 18. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y, Kobayashi T, Yamaguchi H, Sakane H, Ozawa H, Matsuda M, Mikami Y, Mikami Y, Nakamura H.
    Artery; 1993 Dec 15; 20(1):1-18. PubMed ID: 8447724
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
    Bailhache E, Briand F, Nguyen P, Krempf M, Magot T, Ouguerram K.
    Eur J Clin Invest; 2004 Aug 15; 34(8):527-34. PubMed ID: 15305886
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.